ABCB1 polymorphisms are associated with clinical response to nabiximols in patients with multiple sclerosis-related spasticity / A. Gemma, M. Mauri, P. Banfi, M. Versino, A. Zollo, F.M. Boneschi, F. Marino, M. Cosentino, M. Ferrari. - In: JOURNAL OF CANNABIS RESEARCH. - ISSN 2522-5782. - 7:1(2025), pp. 72.1-72.8. [10.1186/s42238-025-00333-4]

ABCB1 polymorphisms are associated with clinical response to nabiximols in patients with multiple sclerosis-related spasticity

F.M. Boneschi;
2025

ABCB1; Multiple sclerosis; Nabiximols; Single nucleotide polymorphisms; Spasticity;
Settore MEDS-12/A - Neurologia
2025
Article (author)
File in questo prodotto:
File Dimensione Formato  
ABCB1 polymorphisms are associated with clinical response to nabiximols in patients with multiple sclerosis-related spasticity .pdf

accesso aperto

Tipologia: Publisher's version/PDF
Licenza: Creative commons
Dimensione 4.32 MB
Formato Adobe PDF
4.32 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/1206496
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
  • OpenAlex 0
social impact